Laura Chiecchio

Salisbury, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Risk adapted therapy for newly diagnosed multiple myeloma delivered through local cytogenetic laboratories in a National Clinical Trial: UKMRA RADAR study.

Risk adapted therapy for newly diagnosed multiple myeloma delivered through local cytogenetic laboratories in a National Clinical Trial: UKMRA RADAR study.

Journal: EJHaem
Published: September 03, 2024

TP53 Mutations Identified Using NGS Comprise the Overwhelming Majority of TP53 Disruptions in CLL: Results From a Multicentre Study.

TP53 Mutations Identified Using NGS Comprise the Overwhelming Majority of TP53 Disruptions in CLL: Results From a Multicentre Study.

Journal: Frontiers in oncology
Published: March 31, 2022

Transmission of diffuse large B-cell lymphoma by an allogeneic stem-cell transplant.

Transmission of diffuse large B-cell lymphoma by an allogeneic stem-cell transplant.

Journal: Haematologica
Published: July 07, 2018

Subclonal TP53 copy number is associated with prognosis in multiple myeloma.

Subclonal TP53 copy number is associated with prognosis in multiple myeloma.

Journal: Blood
Published: June 12, 2018

De novo Richter transformation.

De novo Richter transformation.

Journal: Blood
Published: April 29, 2017

Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL.

Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL.

Journal: Blood
Published: March 28, 2016

Profound parental bias associated with chromosome 14 acquired uniparental disomy indicates targeting of an imprinted locus.

Profound parental bias associated with chromosome 14 acquired uniparental disomy indicates targeting of an imprinted locus.

Journal: Leukemia
Published: April 30, 2015

A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myeloma.

A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myeloma.

Journal: Genes, chromosomes & cancer
Published: June 17, 2014

Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders.

Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders.

Journal: Haematologica
Published: February 29, 2012

Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival.

Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 14, 2011

The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapy.

The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapy.

Journal: Genes, chromosomes & cancer
Published: October 01, 2011
Showing 1-11 of 11

Last Updated: 09/26/2026